CAMBRIDGE, Mass.--Millennium Pharmaceuticals here has appointed six scientists to its scientific advisory board, including Chairman Christopher Walsh, Frank Austen, Gerald Fink, Raju Kucherlapati, Eric Lander, and Harvey Lodish. Mark Levin, Millennium's CEO, commented, "The expertise of these six scientific leaders will further drive Millennium's high-throughput drug discovery platform towards our goal of creating therapeutic products." Millennium is a drug discovery company that makes widespread use of bioinformatics.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.